138 related articles for article (PubMed ID: 20212187)
1. The metabolic syndrome as a cluster of risk factors: is the whole greater than the sum of its parts?: comment on "The metabolic syndrome, its component risk factors, and progression of coronary atherosclerosis".
Ding EL; Smit LA; Hu FB
Arch Intern Med; 2010 Mar; 170(5):484-5. PubMed ID: 20212187
[No Abstract] [Full Text] [Related]
2. Continued popularity of metabolic syndrome as an entity and need for waist circumference measurement.
Jain P
Indian Heart J; 2007; 59(1):13-4. PubMed ID: 19098330
[No Abstract] [Full Text] [Related]
3. Metabolic syndrome and its association with colorectal cancer: a review.
Siddiqui AA
Am J Med Sci; 2011 Mar; 341(3):227-31. PubMed ID: 20460980
[TBL] [Abstract][Full Text] [Related]
4. The hypertriglyceridemic-waist phenotype is associated with the Framingham risk score and subclinical atherosclerosis in Canadian Cree.
Poirier J; Kubow S; Noël M; Dupont C; Egeland GM
Nutr Metab Cardiovasc Dis; 2015 Nov; 25(11):1050-5. PubMed ID: 26474723
[TBL] [Abstract][Full Text] [Related]
5. [Metabolic syndrome as a coronary risk factor. Prevention and treatment].
Kłosiewicz-Latoszek L; Cybulska B
Kardiol Pol; 2003 Jul; 59(7):59-65. PubMed ID: 14560351
[No Abstract] [Full Text] [Related]
6. Independent metabolic syndrome variants predict new-onset coronary artery disease.
Vaidya D; Mathias RA; Kral BG; Yanek LR; Becker LC; Becker DM
Diabetes Care; 2010 Jun; 33(6):1376-8. PubMed ID: 20299483
[TBL] [Abstract][Full Text] [Related]
7. Hypertriglyceridemia is a practical biomarker of metabolic syndrome in individuals with abdominal obesity.
Li Z; Deng ML; Tseng CH; Heber D
Metab Syndr Relat Disord; 2013 Apr; 11(2):87-91. PubMed ID: 23259588
[TBL] [Abstract][Full Text] [Related]
8. [Syndrome X vs metabolic syndrome].
Morales Villegas E
Arch Cardiol Mex; 2006; 76 Suppl 4():S173-88. PubMed ID: 17469345
[TBL] [Abstract][Full Text] [Related]
9. Frequency of metabolic syndrome among hemodialysis patients according to NCEP-ATP III and IDF definitions.
Ucar E; Huzmeli C; Guven O; Savas N; Gullu M; Asilyoruk S; Kuvandik C; Temizkan A; Kuvandik G
Ren Fail; 2009; 31(3):221-8. PubMed ID: 19288328
[TBL] [Abstract][Full Text] [Related]
10. Erectile dysfunction. A predictor of metabolic syndrome?
Craft BJ
Adv Nurse Pract; 2008 Jan; 16(1):57-60. PubMed ID: 20014745
[No Abstract] [Full Text] [Related]
11. Central obesity, the metabolic syndrome, and plasminogen activator inhibitor-1 in young adults.
Appel SJ; Harrell JS; Davenport ML
J Am Acad Nurse Pract; 2005 Dec; 17(12):535-41. PubMed ID: 16293162
[TBL] [Abstract][Full Text] [Related]
12. [From the metabolic syndrome to the concept of global cardiometabolic risk].
Nádas J; Jermendy G
Orv Hetil; 2009 May; 150(18):821-9. PubMed ID: 19383573
[TBL] [Abstract][Full Text] [Related]
13. Metabolic syndrome a widespread threatening condition; risk factors, diagnostic criteria, therapeutic options, prevention and controversies: an overview.
Amihăesei IC; Chelaru L
Rev Med Chir Soc Med Nat Iasi; 2014; 118(4):896-900. PubMed ID: 25581945
[TBL] [Abstract][Full Text] [Related]
14. Metabolic risk factors associated with erosive esophagitis.
Chua CS; Lin YM; Yu FC; Hsu YH; Chen JH; Yang KC; Shih CH
J Gastroenterol Hepatol; 2009 Aug; 24(8):1375-9. PubMed ID: 19467140
[TBL] [Abstract][Full Text] [Related]
15. Diabetes, but not the metabolic syndrome, predicts the severity and extent of coronary artery disease in women.
Zornitzki T; Ayzenberg O; Gandelman G; Vered S; Yaskil E; Faraggi D; Caspi A; Goland S; Shvez O; Schattner A; Knobler H
QJM; 2007 Sep; 100(9):575-81. PubMed ID: 17693419
[TBL] [Abstract][Full Text] [Related]
16. Irbesartan for the treatment of hypertension in patients with the metabolic syndrome: a sub analysis of the Treat to Target post authorization survey. Prospective observational, two armed study in 14,200 patients.
Kintscher U; Bramlage P; Paar WD; Thoenes M; Unger T
Cardiovasc Diabetol; 2007 Apr; 6():12. PubMed ID: 17407587
[TBL] [Abstract][Full Text] [Related]
17. Prevalence of metabolic syndrome components in the type 2 diabetic population who presented coronary artery disease.
Bosevski M; Borozanov V; Gucev F; Bosevska G; Tosev S; Georgievska-Ismail Lj
Prilozi; 2007 Dec; 28(2):161-9. PubMed ID: 18356787
[TBL] [Abstract][Full Text] [Related]
18. The insulin resistance syndrome and coronary artery disease.
Kendall DM; Sobel BE; Coulston AM; Peters Harmel AL; McLean BK; Peragallo-Dittko V; Buse JB; Fonseca VA; Hill JO; Nesto RW; Sunyer FX;
Coron Artery Dis; 2003 Jun; 14(4):335-48. PubMed ID: 12826934
[TBL] [Abstract][Full Text] [Related]
19. Coronary microvascular dysfunction in patients with diabetes, hypertension and metabolic syndrome.
Sucato V; Novo G; Evola S; Novo S
Int J Cardiol; 2015; 186():96-7. PubMed ID: 25814352
[No Abstract] [Full Text] [Related]
20. High prevalence of abdominal obesity increases the risk of the metabolic syndrome in Nigerian type 2 diabetes patients: using the International Diabetes Federation worldwide definition.
Ezenwaka CE; Okoye O; Esonwune C; Onuoha P; Dioka C; Osuji C; Oguejiofor C; Meludu S
Metab Syndr Relat Disord; 2014 Jun; 12(5):277-82. PubMed ID: 24601861
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
